Bethany Gruber, NP
Registered Nurse · Baxley, GANPI 1861828923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 29.8% of the total. Reporting peaked in 2024 at $452 and has fallen 66.5% since, to $152 in 2025.
Across 32 payments — averaging $27.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$264
- AstraZeneca$188
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$136
- E.r. Squibb & Sons, L.L.C.$128
- Novo Nordisk$53
- Corcept Therapeutics$35
- plus $82 from 4 others
What the payments were for
- Food & beverage$887100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $264 |
| AstraZeneca | 3 | $188 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $136 |
| E.r. Squibb & Sons, L.L.C. | 1 | $128 |
| Novo Nordisk | 2 | $53 |
| Corcept Therapeutics | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$887 in reported general payments places this provider in the 85th percentile of 131 registered nurse providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $76,624 |
| MounjaroTirzepatide | 42 | $55,164 |
| VraylarCariprazine Hcl | 23 | $33,939 |
| JardianceEmpagliflozin | 35 | $23,390 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $19,958 |
| TrulicityDulaglutide | 13 | $12,737 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $12,495 |
| Gabapentin | 139 | $1,565 |
| Ziprasidone Hcl | 15 | $1,306 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,104 |
| Levocetirizine Dihydrochloride | 89 | $1,060 |
| Lisinopril | 90 | $816 |
| Levothyroxine Sodium | 110 | $804 |
| Meclizine Hcl | 42 | $769 |
| Nitroglycerin | 14 | $700 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $53 | $76,62469 claims |
| AbbVieVraylar, Armour Thyroid | $264 | $34,31136 claims |
| Boehringer IngelheimJardiance | $20 | $23,39035 claims |
| AstraZenecaBreztri Aerosphere | $188 | $12,49512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 131 registered nurse providers in Georgia.
Other registered nurse in Baxley
- Kristi HarrisonWarner Robins$11K
- Jennifer GardnerGainesville$9K
- Caley AllenDublin$7K
- Andrea MoonSavannah$7K
- Lauren WarrenMacon$6K
- Juliette WilliamsDublin$6K
- Meredith HowardWatkinsville$3K
- Carol LawrenceDalton$3K
- Nicole CampLawrenceville$2K
- Amauwia OkivieSuwanee$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.